0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neurovascular Devices for Hemorrhagic Stroke Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-26B17013
Home | Market Reports | Health| Health Conditions
Global Neurovascular Devices for Hemorrhagic Stroke Market Research Report 2024
BUY CHAPTERS

Global Neurovascular Devices for Hemorrhagic Stroke Market Research Report 2024

Code: QYRE-Auto-26B17013
Report
May 2024
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Neurovascular Devices for Hemorrhagic Stroke Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Neurovascular Devices for Hemorrhagic Stroke Market

Neurovascular Devices for Hemorrhagic Stroke Market

The global Neurovascular Devices for Hemorrhagic Stroke market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Neurovascular Devices for Hemorrhagic Stroke, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurovascular Devices for Hemorrhagic Stroke.

Report Scope

The Neurovascular Devices for Hemorrhagic Stroke market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurovascular Devices for Hemorrhagic Stroke market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurovascular Devices for Hemorrhagic Stroke manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Neurovascular Devices for Hemorrhagic Stroke Market Report

Report Metric Details
Report Name Neurovascular Devices for Hemorrhagic Stroke Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • Support Devices
  • Neurothrombectomy Devices
Segment by Application
  • Hospitals
  • Clinics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Stryker Corporation, Medtronic, Johnson & Johnson, Terumo, Abbott Vascular, Acandis, Cerenovus, Ceres Endovascular, Imperative Care, Penumbra, MicroPort Scientific, NICO Corporation, Phenox, Rapid Medical, Shape Memory Medical, Wallaby Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Neurovascular Devices for Hemorrhagic Stroke manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Neurovascular Devices for Hemorrhagic Stroke in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Neurovascular Devices for Hemorrhagic Stroke Market report?

Ans: The main players in the Neurovascular Devices for Hemorrhagic Stroke Market are Stryker Corporation, Medtronic, Johnson & Johnson, Terumo, Abbott Vascular, Acandis, Cerenovus, Ceres Endovascular, Imperative Care, Penumbra, MicroPort Scientific, NICO Corporation, Phenox, Rapid Medical, Shape Memory Medical, Wallaby Medical

What are the Application segmentation covered in the Neurovascular Devices for Hemorrhagic Stroke Market report?

Ans: The Applications covered in the Neurovascular Devices for Hemorrhagic Stroke Market report are Hospitals, Clinics

What are the Type segmentation covered in the Neurovascular Devices for Hemorrhagic Stroke Market report?

Ans: The Types covered in the Neurovascular Devices for Hemorrhagic Stroke Market report are Support Devices, Neurothrombectomy Devices

1 Neurovascular Devices for Hemorrhagic Stroke Market Overview
1.1 Product Overview and Scope of Neurovascular Devices for Hemorrhagic Stroke
1.2 Neurovascular Devices for Hemorrhagic Stroke Segment by Type
1.2.1 Global Neurovascular Devices for Hemorrhagic Stroke Market Value Comparison by Type (2024-2030)
1.2.2 Support Devices
1.2.3 Neurothrombectomy Devices
1.3 Neurovascular Devices for Hemorrhagic Stroke Segment by Application
1.3.1 Global Neurovascular Devices for Hemorrhagic Stroke Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Neurovascular Devices for Hemorrhagic Stroke Market Size Estimates and Forecasts
1.4.1 Global Neurovascular Devices for Hemorrhagic Stroke Revenue 2019-2030
1.4.2 Global Neurovascular Devices for Hemorrhagic Stroke Sales 2019-2030
1.4.3 Global Neurovascular Devices for Hemorrhagic Stroke Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Neurovascular Devices for Hemorrhagic Stroke Market Competition by Manufacturers
2.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Manufacturers (2019-2024)
2.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Neurovascular Devices for Hemorrhagic Stroke Average Price by Manufacturers (2019-2024)
2.4 Global Neurovascular Devices for Hemorrhagic Stroke Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neurovascular Devices for Hemorrhagic Stroke, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurovascular Devices for Hemorrhagic Stroke, Product Type & Application
2.7 Neurovascular Devices for Hemorrhagic Stroke Market Competitive Situation and Trends
2.7.1 Neurovascular Devices for Hemorrhagic Stroke Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neurovascular Devices for Hemorrhagic Stroke Players Market Share by Revenue
2.7.3 Global Neurovascular Devices for Hemorrhagic Stroke Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neurovascular Devices for Hemorrhagic Stroke Retrospective Market Scenario by Region
3.1 Global Neurovascular Devices for Hemorrhagic Stroke Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Neurovascular Devices for Hemorrhagic Stroke Global Neurovascular Devices for Hemorrhagic Stroke Sales by Region: 2019-2030
3.2.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Region: 2019-2024
3.2.2 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Region: 2025-2030
3.3 Global Neurovascular Devices for Hemorrhagic Stroke Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Region: 2019-2030
3.3.1 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Region: 2019-2024
3.3.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Region: 2025-2030
3.4 North America Neurovascular Devices for Hemorrhagic Stroke Market Facts & Figures by Country
3.4.1 North America Neurovascular Devices for Hemorrhagic Stroke Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2019-2030)
3.4.3 North America Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Neurovascular Devices for Hemorrhagic Stroke Market Facts & Figures by Country
3.5.1 Europe Neurovascular Devices for Hemorrhagic Stroke Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2019-2030)
3.5.3 Europe Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Market Facts & Figures by Country
3.6.1 Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2019-2030)
3.6.3 Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Neurovascular Devices for Hemorrhagic Stroke Market Facts & Figures by Country
3.7.1 Latin America Neurovascular Devices for Hemorrhagic Stroke Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2019-2030)
3.7.3 Latin America Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2019-2030)
3.8.3 Middle East and Africa Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2019-2030)
4.1.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2019-2024)
4.1.2 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Type (2025-2030)
4.1.3 Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2019-2030)
4.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Type (2019-2030)
4.2.1 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Type (2019-2024)
4.2.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Type (2025-2030)
4.2.3 Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Type (2019-2030)
4.3 Global Neurovascular Devices for Hemorrhagic Stroke Price by Type (2019-2030)
5 Segment by Application
5.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2019-2030)
5.1.1 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2019-2024)
5.1.2 Global Neurovascular Devices for Hemorrhagic Stroke Sales by Application (2025-2030)
5.1.3 Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2019-2030)
5.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Application (2019-2030)
5.2.1 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Application (2019-2024)
5.2.2 Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Application (2025-2030)
5.2.3 Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Application (2019-2030)
5.3 Global Neurovascular Devices for Hemorrhagic Stroke Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Stryker Corporation
6.1.1 Stryker Corporation Corporation Information
6.1.2 Stryker Corporation Description and Business Overview
6.1.3 Stryker Corporation Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Stryker Corporation Neurovascular Devices for Hemorrhagic Stroke Product Portfolio
6.1.5 Stryker Corporation Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medtronic Neurovascular Devices for Hemorrhagic Stroke Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson & Johnson Neurovascular Devices for Hemorrhagic Stroke Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Terumo
6.4.1 Terumo Corporation Information
6.4.2 Terumo Description and Business Overview
6.4.3 Terumo Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Terumo Neurovascular Devices for Hemorrhagic Stroke Product Portfolio
6.4.5 Terumo Recent Developments/Updates
6.5 Abbott Vascular
6.5.1 Abbott Vascular Corporation Information
6.5.2 Abbott Vascular Description and Business Overview
6.5.3 Abbott Vascular Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Abbott Vascular Neurovascular Devices for Hemorrhagic Stroke Product Portfolio
6.5.5 Abbott Vascular Recent Developments/Updates
6.6 Acandis
6.6.1 Acandis Corporation Information
6.6.2 Acandis Description and Business Overview
6.6.3 Acandis Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Acandis Neurovascular Devices for Hemorrhagic Stroke Product Portfolio
6.6.5 Acandis Recent Developments/Updates
6.7 Cerenovus
6.6.1 Cerenovus Corporation Information
6.6.2 Cerenovus Description and Business Overview
6.6.3 Cerenovus Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cerenovus Neurovascular Devices for Hemorrhagic Stroke Product Portfolio
6.7.5 Cerenovus Recent Developments/Updates
6.8 Ceres Endovascular
6.8.1 Ceres Endovascular Corporation Information
6.8.2 Ceres Endovascular Description and Business Overview
6.8.3 Ceres Endovascular Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ceres Endovascular Neurovascular Devices for Hemorrhagic Stroke Product Portfolio
6.8.5 Ceres Endovascular Recent Developments/Updates
6.9 Imperative Care
6.9.1 Imperative Care Corporation Information
6.9.2 Imperative Care Description and Business Overview
6.9.3 Imperative Care Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Imperative Care Neurovascular Devices for Hemorrhagic Stroke Product Portfolio
6.9.5 Imperative Care Recent Developments/Updates
6.10 Penumbra
6.10.1 Penumbra Corporation Information
6.10.2 Penumbra Description and Business Overview
6.10.3 Penumbra Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Penumbra Neurovascular Devices for Hemorrhagic Stroke Product Portfolio
6.10.5 Penumbra Recent Developments/Updates
6.11 MicroPort Scientific
6.11.1 MicroPort Scientific Corporation Information
6.11.2 MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Description and Business Overview
6.11.3 MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2019-2024)
6.11.4 MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Product Portfolio
6.11.5 MicroPort Scientific Recent Developments/Updates
6.12 NICO Corporation
6.12.1 NICO Corporation Corporation Information
6.12.2 NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Description and Business Overview
6.12.3 NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2019-2024)
6.12.4 NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Product Portfolio
6.12.5 NICO Corporation Recent Developments/Updates
6.13 Phenox
6.13.1 Phenox Corporation Information
6.13.2 Phenox Neurovascular Devices for Hemorrhagic Stroke Description and Business Overview
6.13.3 Phenox Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Phenox Neurovascular Devices for Hemorrhagic Stroke Product Portfolio
6.13.5 Phenox Recent Developments/Updates
6.14 Rapid Medical
6.14.1 Rapid Medical Corporation Information
6.14.2 Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Description and Business Overview
6.14.3 Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Product Portfolio
6.14.5 Rapid Medical Recent Developments/Updates
6.15 Shape Memory Medical
6.15.1 Shape Memory Medical Corporation Information
6.15.2 Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Description and Business Overview
6.15.3 Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Product Portfolio
6.15.5 Shape Memory Medical Recent Developments/Updates
6.16 Wallaby Medical
6.16.1 Wallaby Medical Corporation Information
6.16.2 Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Description and Business Overview
6.16.3 Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Product Portfolio
6.16.5 Wallaby Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurovascular Devices for Hemorrhagic Stroke Industry Chain Analysis
7.2 Neurovascular Devices for Hemorrhagic Stroke Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurovascular Devices for Hemorrhagic Stroke Production Mode & Process
7.4 Neurovascular Devices for Hemorrhagic Stroke Sales and Marketing
7.4.1 Neurovascular Devices for Hemorrhagic Stroke Sales Channels
7.4.2 Neurovascular Devices for Hemorrhagic Stroke Distributors
7.5 Neurovascular Devices for Hemorrhagic Stroke Customers
8 Neurovascular Devices for Hemorrhagic Stroke Market Dynamics
8.1 Neurovascular Devices for Hemorrhagic Stroke Industry Trends
8.2 Neurovascular Devices for Hemorrhagic Stroke Market Drivers
8.3 Neurovascular Devices for Hemorrhagic Stroke Market Challenges
8.4 Neurovascular Devices for Hemorrhagic Stroke Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Neurovascular Devices for Hemorrhagic Stroke Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Neurovascular Devices for Hemorrhagic Stroke Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Neurovascular Devices for Hemorrhagic Stroke Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Neurovascular Devices for Hemorrhagic Stroke Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Neurovascular Devices for Hemorrhagic Stroke Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Neurovascular Devices for Hemorrhagic Stroke Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Neurovascular Devices for Hemorrhagic Stroke, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Neurovascular Devices for Hemorrhagic Stroke, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Neurovascular Devices for Hemorrhagic Stroke, Product Type & Application
    Table 12. Global Key Manufacturers of Neurovascular Devices for Hemorrhagic Stroke, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Neurovascular Devices for Hemorrhagic Stroke by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurovascular Devices for Hemorrhagic Stroke as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Neurovascular Devices for Hemorrhagic Stroke Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Neurovascular Devices for Hemorrhagic Stroke Sales by Region (2019-2024) & (K Units)
    Table 18. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Region (2019-2024)
    Table 19. Global Neurovascular Devices for Hemorrhagic Stroke Sales by Region (2025-2030) & (K Units)
    Table 20. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Region (2025-2030)
    Table 21. Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Region (2019-2024)
    Table 23. Global Neurovascular Devices for Hemorrhagic Stroke Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Region (2025-2030)
    Table 25. North America Neurovascular Devices for Hemorrhagic Stroke Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2019-2024) & (K Units)
    Table 27. North America Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2025-2030) & (K Units)
    Table 28. North America Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Neurovascular Devices for Hemorrhagic Stroke Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Neurovascular Devices for Hemorrhagic Stroke Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Neurovascular Devices for Hemorrhagic Stroke Sales (K Units) by Type (2019-2024)
    Table 51. Global Neurovascular Devices for Hemorrhagic Stroke Sales (K Units) by Type (2025-2030)
    Table 52. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2019-2024)
    Table 53. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Type (2025-2030)
    Table 54. Global Neurovascular Devices for Hemorrhagic Stroke Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Neurovascular Devices for Hemorrhagic Stroke Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Type (2019-2024)
    Table 57. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Type (2025-2030)
    Table 58. Global Neurovascular Devices for Hemorrhagic Stroke Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Neurovascular Devices for Hemorrhagic Stroke Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Neurovascular Devices for Hemorrhagic Stroke Sales (K Units) by Application (2019-2024)
    Table 61. Global Neurovascular Devices for Hemorrhagic Stroke Sales (K Units) by Application (2025-2030)
    Table 62. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2019-2024)
    Table 63. Global Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Application (2025-2030)
    Table 64. Global Neurovascular Devices for Hemorrhagic Stroke Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Neurovascular Devices for Hemorrhagic Stroke Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Application (2019-2024)
    Table 67. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Application (2025-2030)
    Table 68. Global Neurovascular Devices for Hemorrhagic Stroke Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Neurovascular Devices for Hemorrhagic Stroke Price (US$/Unit) by Application (2025-2030)
    Table 70. Stryker Corporation Corporation Information
    Table 71. Stryker Corporation Description and Business Overview
    Table 72. Stryker Corporation Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Stryker Corporation Neurovascular Devices for Hemorrhagic Stroke Product
    Table 74. Stryker Corporation Recent Developments/Updates
    Table 75. Medtronic Corporation Information
    Table 76. Medtronic Description and Business Overview
    Table 77. Medtronic Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Medtronic Neurovascular Devices for Hemorrhagic Stroke Product
    Table 79. Medtronic Recent Developments/Updates
    Table 80. Johnson & Johnson Corporation Information
    Table 81. Johnson & Johnson Description and Business Overview
    Table 82. Johnson & Johnson Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Johnson & Johnson Neurovascular Devices for Hemorrhagic Stroke Product
    Table 84. Johnson & Johnson Recent Developments/Updates
    Table 85. Terumo Corporation Information
    Table 86. Terumo Description and Business Overview
    Table 87. Terumo Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Terumo Neurovascular Devices for Hemorrhagic Stroke Product
    Table 89. Terumo Recent Developments/Updates
    Table 90. Abbott Vascular Corporation Information
    Table 91. Abbott Vascular Description and Business Overview
    Table 92. Abbott Vascular Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Abbott Vascular Neurovascular Devices for Hemorrhagic Stroke Product
    Table 94. Abbott Vascular Recent Developments/Updates
    Table 95. Acandis Corporation Information
    Table 96. Acandis Description and Business Overview
    Table 97. Acandis Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Acandis Neurovascular Devices for Hemorrhagic Stroke Product
    Table 99. Acandis Recent Developments/Updates
    Table 100. Cerenovus Corporation Information
    Table 101. Cerenovus Description and Business Overview
    Table 102. Cerenovus Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Cerenovus Neurovascular Devices for Hemorrhagic Stroke Product
    Table 104. Cerenovus Recent Developments/Updates
    Table 105. Ceres Endovascular Corporation Information
    Table 106. Ceres Endovascular Description and Business Overview
    Table 107. Ceres Endovascular Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Ceres Endovascular Neurovascular Devices for Hemorrhagic Stroke Product
    Table 109. Ceres Endovascular Recent Developments/Updates
    Table 110. Imperative Care Corporation Information
    Table 111. Imperative Care Description and Business Overview
    Table 112. Imperative Care Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Imperative Care Neurovascular Devices for Hemorrhagic Stroke Product
    Table 114. Imperative Care Recent Developments/Updates
    Table 115. Penumbra Corporation Information
    Table 116. Penumbra Description and Business Overview
    Table 117. Penumbra Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Penumbra Neurovascular Devices for Hemorrhagic Stroke Product
    Table 119. Penumbra Recent Developments/Updates
    Table 120. MicroPort Scientific Corporation Information
    Table 121. MicroPort Scientific Description and Business Overview
    Table 122. MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. MicroPort Scientific Neurovascular Devices for Hemorrhagic Stroke Product
    Table 124. MicroPort Scientific Recent Developments/Updates
    Table 125. NICO Corporation Corporation Information
    Table 126. NICO Corporation Description and Business Overview
    Table 127. NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. NICO Corporation Neurovascular Devices for Hemorrhagic Stroke Product
    Table 129. NICO Corporation Recent Developments/Updates
    Table 130. Phenox Corporation Information
    Table 131. Phenox Description and Business Overview
    Table 132. Phenox Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Phenox Neurovascular Devices for Hemorrhagic Stroke Product
    Table 134. Phenox Recent Developments/Updates
    Table 135. Rapid Medical Corporation Information
    Table 136. Rapid Medical Description and Business Overview
    Table 137. Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. Rapid Medical Neurovascular Devices for Hemorrhagic Stroke Product
    Table 139. Rapid Medical Recent Developments/Updates
    Table 140. Shape Memory Medical Corporation Information
    Table 141. Shape Memory Medical Description and Business Overview
    Table 142. Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 143. Shape Memory Medical Neurovascular Devices for Hemorrhagic Stroke Product
    Table 144. Shape Memory Medical Recent Developments/Updates
    Table 145. Wallaby Medical Corporation Information
    Table 146. Wallaby Medical Description and Business Overview
    Table 147. Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 148. Wallaby Medical Neurovascular Devices for Hemorrhagic Stroke Product
    Table 149. Wallaby Medical Recent Developments/Updates
    Table 150. Key Raw Materials Lists
    Table 151. Raw Materials Key Suppliers Lists
    Table 152. Neurovascular Devices for Hemorrhagic Stroke Distributors List
    Table 153. Neurovascular Devices for Hemorrhagic Stroke Customers List
    Table 154. Neurovascular Devices for Hemorrhagic Stroke Market Trends
    Table 155. Neurovascular Devices for Hemorrhagic Stroke Market Drivers
    Table 156. Neurovascular Devices for Hemorrhagic Stroke Market Challenges
    Table 157. Neurovascular Devices for Hemorrhagic Stroke Market Restraints
    Table 158. Research Programs/Design for This Report
    Table 159. Key Data Information from Secondary Sources
    Table 160. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Neurovascular Devices for Hemorrhagic Stroke
    Figure 2. Global Neurovascular Devices for Hemorrhagic Stroke Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Neurovascular Devices for Hemorrhagic Stroke Market Share by Type in 2023 & 2030
    Figure 4. Support Devices Product Picture
    Figure 5. Neurothrombectomy Devices Product Picture
    Figure 6. Global Neurovascular Devices for Hemorrhagic Stroke Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Neurovascular Devices for Hemorrhagic Stroke Market Share by Application in 2023 & 2030
    Figure 8. Hospitals
    Figure 9. Clinics
    Figure 10. Global Neurovascular Devices for Hemorrhagic Stroke Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Neurovascular Devices for Hemorrhagic Stroke Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Neurovascular Devices for Hemorrhagic Stroke Sales (2019-2030) & (K Units)
    Figure 13. Global Neurovascular Devices for Hemorrhagic Stroke Average Price (US$/Unit) & (2019-2030)
    Figure 14. Neurovascular Devices for Hemorrhagic Stroke Report Years Considered
    Figure 15. Neurovascular Devices for Hemorrhagic Stroke Sales Share by Manufacturers in 2023
    Figure 16. Global Neurovascular Devices for Hemorrhagic Stroke Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Neurovascular Devices for Hemorrhagic Stroke Players: Market Share by Revenue in 2023
    Figure 18. Neurovascular Devices for Hemorrhagic Stroke Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Neurovascular Devices for Hemorrhagic Stroke Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country (2019-2030)
    Figure 21. North America Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country (2019-2030)
    Figure 22. United States Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country (2019-2030)
    Figure 25. Europe Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. U.K. Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Region (2019-2030)
    Figure 33. China Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. China Taiwan Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Indonesia Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Thailand Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Malaysia Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Latin America Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country (2019-2030)
    Figure 43. Latin America Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country (2019-2030)
    Figure 44. Mexico Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Brazil Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Argentina Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Sales Market Share by Country (2019-2030)
    Figure 48. Middle East & Africa Neurovascular Devices for Hemorrhagic Stroke Revenue Market Share by Country (2019-2030)
    Figure 49. Turkey Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Saudi Arabia Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. UAE Neurovascular Devices for Hemorrhagic Stroke Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Global Sales Market Share of Neurovascular Devices for Hemorrhagic Stroke by Type (2019-2030)
    Figure 53. Global Revenue Market Share of Neurovascular Devices for Hemorrhagic Stroke by Type (2019-2030)
    Figure 54. Global Neurovascular Devices for Hemorrhagic Stroke Price (US$/Unit) by Type (2019-2030)
    Figure 55. Global Sales Market Share of Neurovascular Devices for Hemorrhagic Stroke by Application (2019-2030)
    Figure 56. Global Revenue Market Share of Neurovascular Devices for Hemorrhagic Stroke by Application (2019-2030)
    Figure 57. Global Neurovascular Devices for Hemorrhagic Stroke Price (US$/Unit) by Application (2019-2030)
    Figure 58. Neurovascular Devices for Hemorrhagic Stroke Value Chain
    Figure 59. Neurovascular Devices for Hemorrhagic Stroke Production Process
    Figure 60. Channels of Distribution (Direct Vs Distribution)
    Figure 61. Distributors Profiles
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Blood Pressure Mointor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35U11386
Thu Jun 20 00:00:00 UTC 2024

Add to Cart

Global Isosorbide Mononitrate and Glucose Injection Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-8U11347
Wed Jun 19 00:00:00 UTC 2024

Add to Cart

Global Automatic Blood Sugar Monitor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-21E11553
Wed Jun 19 00:00:00 UTC 2024

Add to Cart

Global Closed Chest Drainage Bag Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-5M12588
Tue Jun 18 00:00:00 UTC 2024

Add to Cart